| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 145,855 | 123,118 | 157,700 | 147,926 | | Cost of Revenue | 96,218 | 86,331 | 105,004 | 99,324 | | | Gross Profit | 49,637 | 36,787 | 52,696 | 48,602 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 32,168 | 31,312 | 31,873 | 32,034 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,525 | 3,537 | 3,265 | 3,872 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 13,944 | 1,938 | 17,558 | 12,696 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 10 | | Earnings Before Interest And Taxes | 13,908 | 1,938 | 17,558 | 12,706 | | Interest Expense | (34) | 32 | 2 | 106 | | Income Before Tax | 13,942 | 1,906 | 17,556 | 12,600 | | Income Tax Expense | 5,167 | 797 | 6,644 | 4,967 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,775 | 1,109 | 10,912 | 7,633 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,775 | 1,109 | 10,912 | 7,633 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,775 | $1,109 | $10,912 | $7,633 |
|
1.52% Nasdaq 0.00%
Income Statement
